Scientists found that dormant viral genes can be reactivated in kidney cancer, prompting an immune response, offering new potential for immunotherapy. Dana-Farber researchers have discovered that in ...

Carrillo, MD, evaluates the current state of the global availability of clinical trials for patients with renal cell ...

Are there key genes involved in TKI resistance in ccRCC? What mechanisms are associated with this development? A research team, led by Professor Ben Liu from the Department of Urology at the First ...

The following is a summary of “Retinoid X receptor γ predicts the prognosis and is associated with immune infiltration in ...

Clear cell renal cell carcinoma (ccRCC) is still a clinical challenge due to its high metastasis rate at diagnosis and therapy resistance. It accounts for about 75%-80% of RCC cases. The magnesium ...

Carcinoma is a type of cancer that starts in cells that make up the skin or the tissue lining organs, such as the liver or kidneys. Like other types of cancer, carcinomas are abnormal cells that ...

GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.

The trial marks a significant milestone for Inceptor Bio's efforts to address the unmet medical needs of patients with clear cell Renal Cell Carcinoma (ccRCC) IB-T101 is an autologous CD70 CAR-T ...

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually.